Related references
Note: Only part of the references are listed.N-phenyl-6-chloro-4-hydroxy-2-quinolone-3-carboxamides: Molecular Docking, Synthesis, and Biological Investigation as Anticancer Agents
Dima A. Sabbah et al.
MOLECULES (2021)
Curcumin-tannic acid-poloxamer nanoassemblies enhance curcumin's uptake and bioactivity against cancer cells in vitro
Suhair Sunoqrot et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Molecular Modeling, Synthesis and Biological Evaluation of N-Phenyl-4-Hydroxy-6-Methyl-2-Quinolone-3-CarboxAmides as Anticancer Agents
Dima A. Sabbah et al.
MOLECULES (2020)
Ligand-Based Drug Design: Synthesis and Biological Evaluation of Substituted Benzoin Derivatives as Potential Antitumor Agents
Dima A. Sabbah et al.
MEDICINAL CHEMISTRY (2019)
Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents
Dima A. Sabbah et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride
Zoufeng Xu et al.
INORGANIC CHEMISTRY (2018)
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents
Dima A. Sabbah et al.
MEDICINAL CHEMISTRY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Synthesis, characterization, and anticancer evaluation of some new N1-(anthraquinon-2-yl) amidrazone derivatives
Kamal Sweidan et al.
CANADIAN JOURNAL OF CHEMISTRY (2018)
Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro
Xing Chen et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Facile synthesis, characterization, and cytotoxicity study of new 3-(indol-2-yl)bicyclotetrazatridecahexaens
Kamal Sweidan et al.
CANADIAN JOURNAL OF CHEMISTRY (2017)
Computer-aided design, synthesis, and biological evaluation of new indole-2-carboxamide derivatives as PI3Kα/EGFR inhibitors
Kamal Sweidan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Design, Synthesis and Qualitative Structure Activity Relationship Evaluations of Quinoline-Based Bisarylimidazoles as Antibacterial Motifs
Raed A. Al-Qawasmeh et al.
MEDICINAL CHEMISTRY (2016)
Molecular modeling based approach, synthesis, and cytotoxic activity of novel benzoin derivatives targeting phosphoinostide 3-kinase (PI3Kα)
Dima A. Sabbah et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Computational Docking Studies of Novel Heterocyclic Carboxamides as Potential PI3K alpha Inhibitors
Kamal Sweidan et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2015)
Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds
Raed A. Al-Qawasmeh et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design
Yanlong Zhao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα)
Dima A. Sabbah et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases
Dima A. Sabbah et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Binding Selectivity Studies of Phosphoinositide 3-Kinases Using Free Energy Calculations
Dima A. Sabbah et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer
John T. Isaacs
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Docking Studies on Isoform-Specific Inhibition of Phosphoinositide-3-Kinases
Dima A. Sabbah et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane
Diana Mandelker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms
Li Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations
Chuan-Hsiang Huang et al.
SCIENCE (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
SHED: Shannon Entropy Descriptors from topological feature distributions
Elisabet Gregori-Puigjane et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Fluorine in medicinal chemistry: A review of anti-cancer agents
C Isanbor et al.
JOURNAL OF FLUORINE CHEMISTRY (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
Carboxamide-pyridine N-oxide heterosynthon for crystal engineering and pharmaceutical cocrystals
LS Reddy et al.
CHEMICAL COMMUNICATIONS (2006)
Farnesoid X receptor: From structure to potential clinical applications
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and in vitro anti-proliferative activity of racemic Trifluoro-Casodex® (bicalutamide)
M Sani et al.
LETTERS IN ORGANIC CHEMISTRY (2005)
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Y Samuels et al.
CANCER CELL (2005)
The next generation of phosphodiesterase inhibitors: Structural clues to ligand and substrate selectivity of phosphodiesterases
DT Manallack et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics
Y Sambuy et al.
CELL BIOLOGY AND TOXICOLOGY (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
A highly regio- and stereoselective carbocupration of fluoroalkylated internal alkynes: A short total synthesis of the antiestrogenic drug panomifene
T Konno et al.
ORGANIC LETTERS (2004)
Studies on pyrrolopyrimidines as selective inhibitors of multidrug-resistance-associated protein in multidrug resistance
SM Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Fatigue and cancer: causes, prevalence and treatment approaches
LI Wagner et al.
BRITISH JOURNAL OF CANCER (2004)
Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells
H Sheng et al.
GUT (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
Non-melanoma skin cancers and glucocorticoid therapy
MR Karagas et al.
BRITISH JOURNAL OF CANCER (2001)
Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation
QD Wang et al.
GASTROENTEROLOGY (2001)
Fluoride induces apoptosis by capase-3 activation in human leukemia HL-60 cells
CD Anuradha et al.
ARCHIVES OF TOXICOLOGY (2000)
Share Paper
